Using wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults: toward an early diagnosis of CIPN
Objective - An essential component for optimizing quality of life in adults with cancer is determining the degree to which therapy may negatively impact motor-performance, so that patients can maintain their quality of life and independence. This study examined whether instrumented gait and balance...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
18 January 2019
|
| In: |
Journal of geriatric oncology
Year: 2019, Volume: 10, Issue: 6, Pages: 960-967 |
| ISSN: | 1879-4076 |
| DOI: | 10.1016/j.jgo.2019.01.010 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1016/j.jgo.2019.01.010 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S1879406818303655 
|
| Author Notes: | Mohsen Zahiri, Kevin M. Chen, He Zhou, Hung Nguyen, Biruh T. Workeneh, Sarvari V. Yellapragada, Yvonne H. Sada, Michael Schwenk, Bijan Najafi |
| Summary: | Objective - An essential component for optimizing quality of life in adults with cancer is determining the degree to which therapy may negatively impact motor-performance, so that patients can maintain their quality of life and independence. This study examined whether instrumented gait and balance could determine the magnitude of deterioration in motor-performance from chemotherapy-induced peripheral neuropathy (CIPN). - Methods - We recruited 84 adults with cancer (age=71.1±9.7years old, BMI=26.8±6.2kg/m2, gender=56%female) and 57 age-matched non-cancer patients (age=69.5±9.8years old, BMI=27.1±6.0kg/m2, gender=79%female). Based on clinical screening, the group with cancer was classified into two groups: participants with CIPN (CIPN+) and without CIPN (CIPN-). Gait and balance were quantified using validated wearables. The Vibration Perception Threshold (VPT) test was used to stratify the CIPN+ group into mild (Mild-CIPN) and severe (Severe-CIPN) subgroups. - Results - All gait and balance parameters were deteriorated in the group with cancer compared to non-cancer group with the largest effects observed for stride-time (11%, Cohen's effect size d=1.00, p<0.001) and eyes-closed ankle sway (94%, d=0.49, p=0.001). The same trend was observed when the Severe-CIPN subgroup was compared to the Mild-CIPN. VPT correlates significantly with motor deterioration, with the largest correlation found in stride-time (Rho=0.37, p=0.007). Severe-CIPN subjects were significantly older and overall had more deterioration in the majority of motor-performance parameters after adjusting for age (p<0.050). - Conclusion - These results confirmed the negative impact of CIPN on motor-performance with the largest effects on ankle stability and stride-time. VPT is a predictor of motor deterioration and may be used to determine the severity of CIPN symptom. |
|---|---|
| Item Description: | Gesehen am 02.12.2019 |
| Physical Description: | Online Resource |
| ISSN: | 1879-4076 |
| DOI: | 10.1016/j.jgo.2019.01.010 |